NovoLog - 54868-2777-0 - (insulin aspart)

Alphabetical Index


Drug Information of NovoLog

Product NDC: 54868-2777
Proprietary Name: NovoLog
Non Proprietary Name: insulin aspart
Active Ingredient(s): 100    [iU]/mL & nbsp;   insulin aspart
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of NovoLog

Product NDC: 54868-2777
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020986
Marketing Category: NDA
Start Marketing Date: 20070507

Package Information of NovoLog

Package NDC: 54868-2777-0
Package Description: 1 VIAL, GLASS in 1 CARTON (54868-2777-0) > 10 mL in 1 VIAL, GLASS

NDC Information of NovoLog

NDC Code 54868-2777-0
Proprietary Name NovoLog
Package Description 1 VIAL, GLASS in 1 CARTON (54868-2777-0) > 10 mL in 1 VIAL, GLASS
Product NDC 54868-2777
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name insulin aspart
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20070507
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name INSULIN ASPART
Strength Number 100
Strength Unit [iU]/mL
Pharmaceutical Classes Insulin [Chemical/Ingredient],Insulin Analog [EPC]

Complete Information of NovoLog


General Information